Biotech company Moderna has revealed this week that its coronavirus vaccine has shown promising results in a small trial of elderly people. Moderna tested the vaccine on 10 adults ranging from the age of 56 to 70 and 10 other patients ranging from the age of 71 and older. Each participant received two 100 microgram … Continue reading “Moderna Reveals its Coronavirus Vaccine Has had Promising Results”
Tag: mrna
Biotech & Pharma
President Trump Signs $1.5B Deal with Moderna for 100 Million Doses of Coronavirus Vaccine
This week President Trump announced that the U.S. government has signed a $1.5 billion deal…
August 12, 2020
Biotech & Pharma
CEO of Moderna Thinks Company’s COVID-19 Vaccine is Likely to be Successful
Moderna CEO Stéphane Bancel sees ‘high probability’ of success with the company's Covid-19 vaccine. The…
June 19, 2020
Biotech & Pharma
Moderna Shares Soar on Positive Results on Early Stage Coronavirus Vaccine Trial
Shares of Moderna were surging in Monday's trading session after the company revealed positive data…
May 19, 2020
Hot Stocks
Jim Cramer Said This of Moderna’s IPO Tumble
Shares of biotech company Moderna, which focuses on drug discovery and drug development based on…
December 11, 2018